Breast magnetic resonance imaging findings in women treated with toremifene for premenstrual mastalgia

Acta Radiologica

Volumn 50, Issue 9, 2009, Pages 984-989

  Oksa, S ^a   Parkkola, R ^b   Luukkaala, T ^c   Maenpaa J ^c,d  

^a SATAKUNTA CENTRAL HOSPITAL   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^d TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

Breast; Mastalgia; MRI; Premenstrual syndrome; SERM; Toremifene

Indexed keywords

BREAST; MASTALGIA; MRI; PREMENSTRUAL SYNDROME; SERM; TOREMIFENE;

MAGNETIC RESONANCE;

MAGNETIC RESONANCE IMAGING;

CONTRAST MEDIUM; DIAGNOSTIC AGENT; GADOTERATE MEGLUMINE; MEGLUMINE; ORGANOMETALLIC COMPOUND; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TOREMIFENE;

ADULT; ARTICLE; BREAST DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MENSTRUATION DISORDER; METHODOLOGY; MIDDLE AGED; NONPARAMETRIC TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADULT; BREAST DISEASES; CONTRAST MEDIA; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MEGLUMINE; MENSTRUATION DISTURBANCES; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; SELECTIVE ESTROGEN RECEPTOR MODULATORS; STATISTICS, NONPARAMETRIC; TOREMIFENE; TREATMENT OUTCOME;

EID: 70449092051     PISSN: 02841851     EISSN: 16000455     Source Type: Journal    
DOI: 10.3109/02841850903168083     Document Type: Article

References (19)

1. Ader DN, Shriver CD. Cyclical mastalgia: prevalence and impact in an outpatient breast clinic sample. J Am Coll Surg 1997;/185:/466-70.
2. Smith RL, Pruthi S, Fitzpatrick LA. Evaluation and management of breast pain. Mayo Clin Proc 2004;/79:/ 353-72.
3. BeLieu RM. Mastodynia. Obstet GynecolCl in North Am 1994;/21:/461-7.
4. Kontostolis E, Stefanidis K, Navrozoglou I, Lolis D. Comparison of tamoxifen with danazolfor treatment of cyclical mastalgia. Gynecol Endocrinol 1997;/11:/393-7.
5. Oksa S, Luukkaala T, MäenpääJ. Toremifene for premenstrual mastalgia: a randomised, placebocontrolled crossover study. BJOG 2006;/113:/1-6.
6. Tajima C. Luteotropic effects of tamoxifen in infertile women. FertilSteril 1984;/42:/223-7.
7. Oksa S, Luukkaala T, MäenpääJ. The antioestrogen toremifene has luteotropic effects in women suffering from premenstrualmastal gia. Acta Endocrinol2008; /4:/ 425-32.
8. Leach MO. Breast cancer screening in women at high risk using MRI. NMR Biomed 2009;/22:/17-27.
9. Partridge SC. Future applications and innovations of clinical breast magnetic resonance imaging. Top Magn Reson Imaging 2008;/19:/171-6.
10. Eng-Wong J, Orzano-Birgani J, Chow CK, Venzon D, Yao J, Galbo CE, et al. Effect of raloxifene on mammographic density and breast magnetic resonance imaging in premenopausalwomen at increased risk for breast cancer. Cancer EpidemiolBiomarkers Prev 2008;/ 17:/1696-701.
11. American College of Radiology. Breast imaging reporting and data system atlas (BI-RADS atlas). Reston, VA: American College of Radiology; 2003.
12. Salokangas RKR, Poutanen O, Stengard E. Screening for depression in primary care. Development and validation of the Depression Scale, a screening instrument for depression. Acta Psychiatr Scand 1995;/92:/ 10-6.
13. Fowler PA, Casey CE, Cameron GG, Foster MA, Knight CH. Cyclic changes in composition and volume of the breast during the menstrualcycl e, measured by magnetic resonance imaging. Br J Obstet Gynaecol 1990;/97:/595-602.
14. Hussain Z, Roberts N, Whitehouse GH, Garcí a-Fiñ ana, Percy D. Estimation of breast volume and its variation during the menstrual cycle using MRI and stereology. Br J Radiol1999;72:236-45.
15. KuhlCK, Bieling HB, Gieseke J, Kreft BP, Sommer T, Lutterberg G, et al. Healthy premenopausal breast parenchyma in dynamic contrast-enhanced MR imaging of the breast: Normalcontrast medium enhancement and cyclical-phase dependency. Radiology 1997;/203:/ 137-44.
16. Delille J-P, Slanetz PJ, Yeh ED, Kopans DB, Garrido L. Physiologic changes in breast magnetic resonance imaging during the menstrualcycl e: perfusion imaging, signalenhancement, and in.uence of the T1 relaxation time of breast tissue. Breast J 2005;/11:/236-41.
17. Heywang-Köbrunner SH, Viehweg P, Heinig A, Küchler C. Contrast-enhanced MRI of the breast: accuracy, value, controversies, solutions. Eur J Radiol 1997;/24:/ 94-108.
18. Cuzick J, Forbes J, Edwards R, Baum R, Cawthorn S, Coates A, et al. First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial. Lancet 2002;/360:/817-24.
19. Cuzick J, Warwick J, Pinney E, Warren RM, Duffy SW. Tamoxifen and breast density in women at increased risk of breast cancer. J NatlCancer Inst 2004;/96:/621-8.